<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5578992</article-id><article-id pub-id-type="publisher-id">10474</article-id><article-id pub-id-type="doi">10.1038/s41598-017-10474-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Prolonged AT<sub>1</sub>R activation induces Ca<sub>V</sub>1.2 channel internalization in rat cardiomyocytes</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Hermosilla</surname><given-names>Tamara</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Encina</surname><given-names>Mat&#x000ed;as</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Morales</surname><given-names>Danna</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Moreno</surname><given-names>Cristian</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Conejeros</surname><given-names>Carolina</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Alfaro-Vald&#x000e9;s</surname><given-names>Hilda M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lagos-Meza</surname><given-names>Felipe</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Simon</surname><given-names>Felipe</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Altier</surname><given-names>Christophe</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Varela</surname><given-names>Diego</given-names></name><address><email>dvarela@bitmed.med.uchile.cl</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Programa de Fisiopatolog&#x000ed;a, Instituto de Ciencias Biom&#x000e9;dicas, </institution><institution>Facultad de Medicina, Universidad de Chile, </institution></institution-wrap>Santiago, 8380453 Chile </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2156 804X</institution-id><institution-id institution-id-type="GRID">grid.412848.3</institution-id><institution>Departamento de Ciencias Biol&#x000f3;gicas, </institution><institution>Facultad de Ciencias Biol&#x000f3;gicas and Facultad de Medicina, Universidad Andr&#x000e9;s Bello, </institution></institution-wrap>Avenida Republica 239, Santiago, 8370146 Chile </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7697</institution-id><institution-id institution-id-type="GRID">grid.22072.35</institution-id><institution>Department of Physiology and Pharmacology and Snyder Institute for Chronic Diseases, </institution><institution>University of Calgary, </institution></institution-wrap>Calgary, T2N 4N1 Canada </aff><aff id="Aff4"><label>4</label>Millennium Institute on Immunology and Immunotherapy, Santiago, 8331150 Chile </aff><aff id="Aff5"><label>5</label>Millennium Nucleus of Ion Channels-Associated Diseases (MiNICAD), Santiago, Chile </aff></contrib-group><pub-date pub-type="epub"><day>31</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>7</volume><elocation-id>10131</elocation-id><history><date date-type="received"><day>6</day><month>2</month><year>2017</year></date><date date-type="accepted"><day>10</day><month>8</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The cardiac L-type calcium channel is a multi-subunit complex that requires co-assembling of the pore-forming subunit Ca<sub>V</sub>1.2 with auxiliary subunits Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4; and Ca<sub>V</sub>&#x003b2;. Its traffic has been shown to be controlled by these subunits and by the activation of various G-protein coupled receptors (GPCR). Here, we explore the consequences of the prolonged activation of angiotensin receptor type 1 (AT<sub>1</sub>R) over Ca<sub>V</sub>1.2 channel trafficking. Bioluminescence Resonance Energy Transfer (BRET) assay between &#x003b2;-arrestin and L-type channels in angiotensin II-stimulated cells was used to assess the functional consequence of AT<sub>1</sub>R activation, while immunofluorescence of adult rat cardiomyocytes revealed the effects of GPCR activation on Ca<sub>V</sub>1.2 trafficking. Angiotensin II exposure results in &#x003b2;-arrestin<sub>1</sub> recruitment to the channel complex and an apparent loss of Ca<sub>V</sub>1.2 immunostaining at the T-tubules. Accordingly, angiotensin II stimulation causes a decrease in L-type current, Ca<sup>2+</sup> transients and myocyte contractility, together with a faster repolarization phase of action potentials. Our results demonstrate that prolonged AT<sub>1</sub>R activation induces &#x003b2;-arrestin<sub>1</sub> recruitment and the subsequent internalization of Ca<sub>V</sub>1.2 channels with a half-dose of AngII on the order of 100&#x02009;nM, suggesting that this effect depends on local renin-angiotensin system. This novel AT<sub>1</sub>R-dependent Ca<sub>V</sub>1.2-trafficking modulation likely contributes to angiotensin II-mediated cardiac remodeling.</p></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">In mammals, the renin-angiotensin system (RAS) is one of the key factors in the regulation of blood pressure, electrolyte balance and cardiac function. Renin catalyzes the conversion of the 14 amino acid propeptide angiotensinogen into angiotensin I (AngI), which in turn is cleaved by the angiotensin-converting enzyme (ACE) to produce angiotensin II (AngII)<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. AngII participates in a series of intracellular signaling cascades via activation of its receptors AT<sub>1</sub> and AT<sub>2</sub>, which belong to the superfamily of seven-transmembrane domain G-protein coupled receptors (GPCR)<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>.</p><p id="Par3">Most of the classical actions associated with AngII are dependent on the activation of the AT<sub>1</sub> receptor (AT<sub>1</sub>R)<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Binding of AngII results in rapid phosphorylation of the receptor that facilitates &#x003b2;-arrestin recruitment induced desensitization and internalization of AT<sub>1</sub>R<sup><xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref></sup>. Thus, activated AT<sub>1</sub>R is phosphorylated by GPCR kinases (GRKs) and subsequently &#x003b2;-arrestin is recruited to the receptor. This receptor/&#x003b2;-arrestin interaction leads to receptor desensitization, ending the G protein-dependent signaling by interfering with the coupling between the G protein and its receptor. Furthermore, &#x003b2;-arrestin can also bind to components of the clathrin coat, causing internalization of activated receptors and target to degradation pathways or recycled back to the cell surface<sup><xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref></sup>.</p><p id="Par4">Several recent studies have demonstrated the existence of macromolecular complexes involving GPCRs and various ion channels. For example, the dopamine D1 receptor regulates the NMDA receptor through a direct interaction<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. AT<sub>1</sub>R co-immunoprecipitates with the non-selective cation channel TRPV4<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> and with K<sub>V</sub>4.3, which is responsible for the fast transient outward current (I<sub>to</sub>) in cardiac myocytes<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Likewise, it has been shown that voltage dependent calcium channels (VDCC) interact with various GPCRs. For instance, N-type Ca<sup>2+</sup> channels interact with ORL1<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>, GABAb<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> and the dopamine D1<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> and D2<sup><xref ref-type="bibr" rid="CR12">12</xref></sup> receptors. Interestingly, most of these interactions lead to endocytosis of the channel following activation of the respective receptor<sup><xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref></sup>.</p><p id="Par5">In general, VDCCs are protein complexes involving at least three subunits: a Ca<sub>V</sub>&#x003b1;<sub>1</sub> subunit that forms the channel pore, and Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4; and Ca<sub>V</sub>&#x003b2; accessory subunits, responsible for trafficking of the channel complex<sup><xref ref-type="bibr" rid="CR14">14</xref></sup> to the plasma membrane. In cardiomyocytes, LTCC clusters, with specific subcellular localization, have been associated with specific functions. Thus, LTCC localized at the T-tubules are mainly responsible for excitation-contraction coupling by its association with ryanodine receptor 2 (RyR2) channels, while LTCC localized at the sarcolemma are implicated in signaling to the nucleus and regulation of gene transcription<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>.</p><p id="Par6">Several studies have convincingly shown that AngII modulates L-type currents. However, this modulation appears to depend on the cell type and on the species studied. For example, AngII induces an increase of L-type currents in smooth muscle cells<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> by a PI3Kdependent mechanism<sup><xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref></sup>, while in neurons<sup><xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref></sup> and in glomerular cells, a decrease in these currents has been observed via a Pertussis toxin sensitive G-protein pathway<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>.</p><p id="Par7">In cardiomyocytes, the effect on this current after AngII application has been shown to be dependent on the species and the patch-clamp configuration used. In hamster<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> and guinea pig<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> the L-type current is increased, while in rabbit<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> and cat<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> no change is observed in cells studied with conventional whole-cell (WC) recordings, in contrast, perforated patch experiments show a potentiation of the L-type current. Finally, in rat<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> and human<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> a decrease of the L-type current has been reported using the conventional WC configuration, while the use of perforated patch configuration in newborn rat cardiomyocytes shows that the degree of L-type current inhibition depend on the speed of inactivation of L-type currents<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. This evidence together with a growing number of reports, establishes a clear link between VDCC and GPCRs, suggesting the existence of a functional association between L-type calcium channels and AT<sub>1</sub>R.</p><p id="Par8">In this work, we demonstrate that AngII stimulation of AT<sub>1</sub>R causes &#x003b2;-arrestin<sub>1</sub> (but not &#x003b2;-arrestin<sub>2</sub>) recruitment of the L-type calcium channel complex. From a functional stand point, AT<sub>1</sub>R activation induces internalization of the T-tubule Ca<sub>V</sub>1.2 population after prolonged exposure to AngII, leading to ~60% reduction of endogenous L-type calcium currents, diminished calcium transient amplitude, and reduced action potential duration.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Methods</title><sec id="Sec3"><title>Constructs</title><p id="Par9">cDNA encoding the angiotensin receptor 1, AT<sub>1</sub>R (NM_000685), was obtained from the University of Missouri-Rolla cDNA resource center. cDNAs for calcium channel subunits (GenBank&#x02122; accession numbers: X15539 (Ca<sub>V</sub>1.2) and AF286488 (Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4;<sub>1</sub>) were kindly provided by Dr. T. Snutch. Ca<sub>V</sub>&#x003b2;<sub>2b</sub> channel subunit (AF423193) was cloned as described in Moreno <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. The HA epitope inserted into the extracellular S5-H5 loop of domain II of Ca<sub>V</sub>1.2 for the HA-tagged Ca<sub>V</sub>1.2 construct is described previously<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Ca<sub>V</sub>1.2-YFP and Ca<sub>V</sub>&#x003b2;<sub>1b</sub>-YFP were PCR amplified and subcloned into the N1-YFP vector (Clontech) between the NheI and BamHI or EcoRI and BamHI restriction sites respectively. &#x003b2;-arrestin-Rluc constructs were kindly provided by Dr. R. Ramachandran and AT<sub>1</sub>R-YFP construct was kindly provided by Dr. LM Luttrell.</p></sec><sec id="Sec4"><title>AD-293 culture and transfection</title><p id="Par10">Tissue culture of AD-293 cells (Agilent) was performed as recommended by the distributor. Transfection solutions for individual culture dishes (35 mm diameter) contained a mixture of cDNA expression vectors (1&#x02009;&#x003bc;g for each L-type calcium channel subunits (Ca<sub>V</sub>&#x003b1;, Ca<sub>V</sub>&#x003b2; and Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4; subunits), 1&#x02009;&#x003bc;g of AT<sub>1</sub>R and 100 ng of &#x003b2;-arrestin-RLuc) and were transfected into cells by the calcium phosphate method<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Experiments were conducted at room temperature 2&#x02013;3 days after transfection.</p></sec><sec id="Sec5"><title>Isolation of cardiomyocytes</title><p id="Par11">Rats were bred in the Animal Breeding Facility from the Facultad de Medicina, Universidad de Chile (Santiago, Chile). All studies were done in accordance and with the approval of the Universidad de Chile Institutional Bioethical Committee. Male Sprague Dawley rats (150&#x02013;200&#x02009;gr) were anaesthetized with ketamine plus xylazine and euthanized by isoflurane overdose before heart excision. Ventricular myocytes were isolated by enzymatic digestion in a Langendorff perfusion apparatus. Briefly, the hearts were removed, mounted on a Langendorff apparatus and perfused with modified Tyrode solution containing (mM): 133.5 NaCl, 1.2 NaH<sub>2</sub>PO<sub>4</sub>, 4 KCl, 1.8 CaCl<sub>2</sub>, 1.2 MgSO<sub>4</sub>, 10 HEPES and 5.5 glucose (pH 7.4 with NaOH) to wash out residual blood in the coronary vessels, Ca<sup>2+</sup> was replaced with 5&#x02009;mM EGTA after 3&#x02009;min wash. Digestion was done by perfusion of the heart with modified Tyrode solution containing 25&#x02009;&#x000b5;M Ca<sup>2+</sup>, 0.45&#x02009;mg/ml collagenase type II (Worthington) and 0.12&#x02009;mg/ml protease IV (Sigma-Aldrich) at 37&#x02009;&#x000b0;C for 7&#x02009;min, after which the Ca<sup>2+</sup> concentration was increased to 50&#x02009;&#x000b5;M for 7&#x02009;min and further to 400&#x02009;&#x000b5;M for 5&#x02009;min. Subsequently, the heart was removed from the Langendorff apparatus and the dissociated cardiomyocytes were suspended in 400&#x02009;&#x000b5;M Ca<sup>2+</sup>-Tyrode solution containing 1&#x02009;mg/ml BSA, 30&#x02009;mM taurine and 5&#x02009;mM pyruvate at room temperature, and the Ca<sup>2+</sup> concentration was gradually increased to 1.8&#x02009;mM. Adult rat cardiomyocytes were cultured on laminin-coated coverslips (10&#x02009;&#x000b5;g/ml) for 2 hr prior to AngII stimulation.</p></sec><sec id="Sec6"><title>Bioluminescence resonance energy transfer (BRET)</title><p id="Par12">AD-293 cells were co-transfected with Ca<sub>V</sub>1.2-YFP and &#x003b2;-arrestin-Rluc fusion proteins (+Ca<sub>V</sub>&#x003b2; and Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4;) or Ca<sub>V</sub>&#x003b2;-YFP and &#x003b2;-arrestin-Rluc fusion proteins (+Ca<sub>V</sub>1.2 and Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4;). After 48&#x02009;hours, cells were seeded into a 96-well microplate and coelenterazine H was added 10&#x02009;minutes before AngII. Ca<sub>V</sub>1.2 recruitment of &#x003b2;-arrestin was detected every 25&#x02009;seconds as the ratio of the light intensity measured at 535&#x02009;&#x000b1;&#x02009;20 over 475&#x02009;&#x000b1;&#x02009;20&#x02009;nm using a Tecan fluorometer. BRET signal of cells expressing YFP and Rluc was compared with cells overexpressing only Rluc as control. Every BRET experiment was performed at a controlled temperature of 23&#x02009;&#x000b0;C.</p></sec><sec id="Sec7"><title>Antibody feeding assays</title><p id="Par13">AD-293 cells over-expressing hemagglutinin-epitope (HA-epitope) tagged Ca<sub>V</sub>1.2 (+Ca<sub>V</sub>&#x003b2; and Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4;<sub>1</sub>) and AT<sub>1</sub>R were incubated with anti-HA antibody (Roche) for 30&#x02009;min at 37&#x02009;&#x000b0;C. Subsequently, cells were stimulated with AngII (1&#x02009;&#x000b5;M), washed with Hank&#x02019;s solution and fixed with 4% paraformaldehyde. Surface-remaining Ca<sub>V</sub>1.2 channels were labeled with a secondary antibody (1:1000) conjugated to Alexa Fluor 488 (green, Invitrogen) in PBS. Then, cells were permeabilized with 0.5% triton in PBS (+1% BSA) and total Ca<sub>V</sub>1.2 channels were labeled with a secondary antibody (1:1000) conjugated to Alexa Fluor 594 (red, Invitrogen) in PBS. For image analysis, images were collected on an inverted microscope (Olympus IX-81, UPLFLN 40XO 40x/1.3 oil-immersion objective) and acquired using CellR software (Olympus). All image analyses were performed with ImageJ.</p><p id="Par14">To analyze HA-epitope-tagged Ca<sub>V</sub>1.2 internalization, the green signal was converted to a binary image by setting the threshold function to the onset of the frequency of staining intensities histogram. With this procedure, any green pixel (independent of its original intensity) is set to maximal intensity. To obtain the percentage of internalized channels, the resultant binary image was subtracted from the red signal. This new red-signal image represents the number of internalized channels and the integrated intensities were normalized by dividing them with the integrated intensity of the red signal (that represents the total amount of channels, see Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>).</p></sec><sec id="Sec8"><title>Immunofluorescence</title><p id="Par15">Adult rat cardiomyocytes were seeded on laminin pretreated coverslips and then incubated with AngII (1&#x02009;&#x000b5;M) in the presence or absence of Losartan (100&#x02009;nM) (Sigma). Subsequently, cardiomyocytes were washed with PBS and fixed with 4% paraformaldehyde. Cardiomyocytes were then permeabilized with 0.02% Triton X-100 in blocking buffer (3% BSA, 5% goat serum in PBS) and incubated for 16&#x02009;hours with primary antibodies (Anti-Ca<sub>V</sub>1.2, Alomone #ACC-003, rabbit polyclonal, Anti- &#x003b2;arrestin<sub>1/2</sub>, Santa Cruz #SC-53781, mouse monoclonal, Anti-&#x003b1;Actinin, Abcam #AB-9465, mouse monoclonal) before addition of fluorescently labeled secondary antibodies and visualization by confocal microscopy. Intracellular signal percentage was calculated by integrating the cardiomyocyte surface fluorescence (defined by hand for each image) and subtracting it from the total integrated fluorescence. This ensuing signal was then normalized to the total integrated fluorescence.</p></sec><sec id="Sec9"><title>Colocalization analysis</title><p id="Par16">Intensity Correlation Analysis, performed as described previously<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>, is based on the principle that when two proteins colocalize their staining intensities should vary synchronously<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Briefly, the Product of the Differences from the Mean (PDM) of each pixel was calculated and the Intensity Correlation Quotient (ICQ) was defined as the ratio of the number of positive PDM pixels to the total pixel numbers. The ICQ values are distributed between &#x02212;0.5 and&#x02009;+0.5 by subtracting 0.5 from this ratio and a dependent staining is considered when the ICQ value range between 0&#x02009;&#x0003c;&#x02009;ICQ&#x02009;&#x02264;&#x02009;+&#x02009;0.5.</p></sec><sec id="Sec10"><title>Calcium Imaging</title><p id="Par17">Plated cardiomyocytes were mounted in a perfusion chamber on the stage of an inverted microscope (Olympus IX-81, UPLFLN 40XO 40 x/1.3 oil-immersion objective). Fluorescence was collected using a CCD-based imaging system (Olympus DSU) running CellR software (Olympus). Cardiomyocytes were incubated with Fluo-4 (Molecular Probes, 1&#x02009;&#x000b5;M) as described in ref. <xref ref-type="bibr" rid="CR28">28</xref> and thoroughly washed with external solution (mM): 100 NaCl, 5 KCl, 2 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 90 sorbitol, 5 glucose and 10 HEPES (pH 7.4 adjusted with Tris-Base). Fluo-4 loaded cardiomyocytes were excited at 480&#x02009;nm and the fluorescence emission at 510&#x02009;nm was collected and recorded at 12&#x02009;Hz. For each experiment, signals were recorded and the background intensity subtracted using equivalent regions of interest (ROI) outside the cardiomyocytes. Fluo-4 results are expressed as normalized fluorescence (F/F<sub>0</sub>).</p></sec><sec id="Sec11"><title>Electrophysiology and data analysis</title><p id="Par18">Ca<sup>2+</sup> currents were recorded by conventional whole-cell patch clamp<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. Borosilicate glass pipettes were pulled to 2&#x02013;4 M&#x003a9; resistance and filled with internal solution containing (mM): 108 CsCl, 4 MgCl<sub>2</sub>, 2 CaCl<sub>2</sub>, 10 EGTA 10 HEPES, 5 MgATP and 0.6 LiGTP (pH 7.2 adjusted with CsOH). The bath solution contained (mM): 5 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 10 HEPES, 20 TEA-Cl, 10 glucose and 100 NMDG-Cl (pH 7.4 adjusted with Tris). Data were acquired at room temperature using an Axopatch 200B amplifier and pClamp 10 software (Axon Instruments), low pass-filtered at 5&#x02009;kHz, and digitized at 10&#x02009;kHz. Series resistance was compensated to 85%. Data analysis, currents fitting and offline leak subtraction were performed in Clampfit 10 (Axon Instruments), and SigmaPlot 11 (Jandel Scientific). Current-voltage (IV) plots were fitted using a modified Boltzmann equation:<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$I=\frac{{G}_{{\rm{\max }}}\ast (V-{E}_{rev})}{1+{e}^{-(V-{V}_{a})/k}}$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">max</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02217;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>V</mml:mi><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>V</mml:mi><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>/</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="41598_2017_10474_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>where <italic>E</italic>
<sub><italic>rev</italic></sub> is the reversal potential, G<sub>max</sub> is the maximum slope conductance, <italic>k</italic> is the slope factor, and <italic>V</italic>
<sub><italic>a</italic></sub> the half-activation potential.</p><p id="Par19">For action potential (AP) recordings, current-clamp mode was used and APs were elicited by 1&#x02009;min trains of short (2 ms) depolarizing current injections at a frequency of 1&#x02009;Hz, the average of the last 30 APs was used for analysis. Intracellular solution for these recordings was (mM): 120 KCl, 1.5 MgCl<sub>2</sub>, 0.01 CaCl<sub>2</sub>, 0.5 EGTA, 10 HEPES, 5 MgATP and 0.6 LiGTP (pH 7.2 adjusted with KOH). Extracellular solution was: 140 NaCl, 4 KCl, 1 MgCl<sub>2</sub>, 2 CaCl<sub>2</sub>, 10 Glucose and 10 HEPES (pH 7.4 adjusted with NaOH).</p></sec><sec id="Sec12"><title>Measurement of myocyte shortening</title><p id="Par20">Contractile properties of isolated ventricular myocytes were determined by measuring the fractional shortening of single cell cardiomyocyte at room temperature and superfused with external solution (mM): 100 NaCl, 5 KCl, 2 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 90 sorbitol, 5 glucose and 10 HEPES (pH 7.4 adjusted with Tris-Base). Myocytes were field-stimulated with 2 ms pulses at 1&#x02009;Hz. Cardiomyocyte shortening and relengthening was measured on the stage of an inverted microscope (Olympus IX-81, UPLFLN 40XO 40 x/1.3 oil-immersion objective) using a CCD-based imaging system in which the myocyte motion was collected and recorded at 12&#x02009;Hz and analyzed with ImageJ.</p></sec><sec id="Sec13"><title>Statistics</title><p id="Par21">Data are presented as mean&#x02009;&#x000b1;&#x02009;sem (n). Statistical analysis of the data was performed with SigmaPlot 11 (Jandel Scientific) using unpaired Student&#x02019;s <italic>t</italic>-test, and was considered significant at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05. One-way ANOVA test was performed for samples exposed to multiple treatments and was considered significant at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></sec></sec><sec id="Sec14" sec-type="results"><title>Results</title><p id="Par22">In live cells, &#x003b2;-arrestin recruitment to activated AT<sub>1</sub>R can be measured by the bioluminescence energy transfer (BRET) assay<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. AngII stimulated AD-293 cells overexpressing &#x003b2;-arrestin<sub>1</sub>/Rluc or &#x003b2;-arrestin<sub>2</sub>/Rluc together with AT<sub>1</sub>R/YFP display an increased BRET signal within the first minutes of stimulation (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1A</xref>). Notably, overexpression of L-type calcium channels (Ca<sub>V</sub>1.2, Ca<sub>V</sub>&#x003b2; and Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4;) in the same cells did not change the BRET signal (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1B</xref>). Given the fact that BRET can only occur between particles located within ~100&#x02009;&#x000c5; from each other, this approach enables the study of the AngII-mediated interaction between &#x003b2;-arrestin and Ca<sub>V</sub>1.2 channels in live cells. As shown in Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>, a significant increase in BRET signal is observed upon AngII treatment only in those AD-293 cells expressing &#x003b2;-arrestin<sub>1</sub>/Rluc, AT<sub>1</sub>R and a YFP-tagged L-type calcium channel (Ca<sub>V</sub>1.2/YFP, Ca<sub>V</sub>&#x003b2; and Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4;), confirming the close proximity between Ca<sub>V</sub>1.2 complexes and activated AT<sub>1</sub>R. However, C-terminal fusion of YFP to the Ca<sub>V</sub>1.2 &#x003b1; subunit resulted in a relatively small BRET signal. Therefore, the experiment was modified to enhance the BRET signal by fusing YFP to the C-terminus of the Ca<sub>V</sub>&#x003b2; subunit (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1C and D</xref>), as Ca<sub>V</sub>&#x003b2; subunits has been shown to have physiological functions in the absence of Ca<sub>V</sub>&#x003b1; subunits<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. Besides the usual negative control (cells without the YFP construct), for these experiments we used cells expressing all the constructs, except Ca<sub>V</sub>1.2 (&#x003b2;-arrestin<sub>1</sub>/Rluc, AT<sub>1</sub>R, Ca<sub>V</sub>&#x003b2;/YFP and Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4;). Under this configuration, we detected significant BRET signal changes upon AngII stimulation in those cells expressing &#x003b2;-arrestin<sub>1</sub>/Rluc, AT<sub>1</sub>R and the YFP-tagged LTCC channel subunits (Ca<sub>V</sub>1.2, Ca<sub>V</sub>&#x003b2;/YFP and Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4;). Those cells lacking in Ca<sub>V</sub>1.2 (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1C and D</xref>) or AT<sub>1</sub>R (not shown) revealed no detectable changes in BRET signal. Interestingly, we only observed an increase in BRET signal upon &#x003b2;-arrestin<sub>1</sub> (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1C</xref>) but not with &#x003b2;-arrestin<sub>2</sub> overexpression (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1D</xref>), even though AT<sub>1</sub>R activation is able to recruit both &#x003b2;-arrestin isoforms (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1A and B</xref>)<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Importantly, under our experimental conditions AngII increased the net BRET signal in a concentration-dependent manner with an apparent EC<sub>50</sub> of 130&#x02009;&#x000b1;&#x02009;50&#x02009;nM (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1E</xref>, n&#x02009;=&#x02009;3).<fig id="Fig1"><label>Figure 1</label><caption><p>BRET assay between AT<sub>1</sub>R or Ca<sub>V</sub>1.2 channel and &#x003b2;-arrestins upon AngII stimulation. Time course of BRET signal ratio from AD-293 cells transfected with &#x003b2;-arrestin<sub>1</sub>-RLuc (black circles) or &#x003b2;-arrestin<sub>2</sub>-RLuc (grey circles) plus AT<sub>1</sub>R-YFP alone <bold>(A)</bold> or AT<sub>1</sub>R-YFP plus the L-type calcium channel (Ca<sub>V</sub>1.2, Ca<sub>V</sub>&#x003b2; and Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4;) <bold>(B)</bold>. For negative controls (empty circles), AD-293 cells were transfected without the &#x003b2;-arrestins. Time course of BRET signal ratio from AD-293 cells transfected with &#x003b2;-arrestin<sub>1</sub>-RLuc (<bold>C</bold>) or &#x003b2;-arrestin<sub>2</sub>-RLuc (<bold>D</bold>) plus AT<sub>1</sub>R and a YFP-tagged L-type calcium channel (Ca<sub>V</sub>1.2, Ca<sub>V</sub>&#x003b2;/YFP and Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4;). For negative controls (empty circles), AD-293 cells were transfected without the Ca<sub>V</sub>1.2 subunit. Red lines correspond to the best fit to a single rectangular hyperbola. The BRET records are averages of at least five independent experiments (n&#x02009;=&#x02009;5&#x02013;8). (<bold>E</bold>) Concentration-response curve of AngII-induced increase in net BRET signal in AD-293 cells transfected with &#x003b2;-arrestin<sub>1</sub>-RLuc plus AT<sub>1</sub>R and a YFP-tagged L-type calcium channel (Ca<sub>V</sub>1.2, Ca<sub>V</sub>&#x003b2;/YFP and Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4;), the line correspond to the best fit to Hill equation, n&#x02009;=&#x02009;3. Mean values&#x02009;&#x000b1;&#x02009;sem are shown.</p></caption><graphic xlink:href="41598_2017_10474_Fig1_HTML" id="d29e1216"/></fig>
</p><p id="Par23">To confirm &#x003b2;-arrestin recruitment to the L-type channel macrocomplex in native cells, adult rat cardiomyocytes were isolated and stimulated with AngII. As expected for Ca<sub>V</sub>1.2 immunostaining, L-type calcium channels were observed in a regularly spaced array consistent with the arrangement pattern of T-tubules, as well as surface sarcolemmal staining (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2A</xref> and Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">3</xref>) which highlights different populations of LTCC in cardiomyocytes<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. Moreover, immunostaining with a &#x003b2;-arrestin<sub>1/2</sub> antibody revealed that in the absence of agonist, these proteins are distributed along the T-tubules and the plasmalemma with a small cluster found into the nucleus (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2A</xref>). A higher amount of &#x003b2;-arrestin<sub>1/2</sub> into the T-tubule network was readily observed upon addition of AngII (30&#x02009;min, 1&#x02009;&#x000b5;M, Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2B</xref>). To estimate the degree of colocalization of both proteins at the plasma membrane we submitted our data to intensity correlation analysis<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, a methodology that assumes that if two proteins colocalize, their fluorescence intensities should vary synchronically above the mean fluorescence (see methods). Intensity correlation analysis revealed an increase in the mean Intensity Correlation Quotient (ICQ) values for Ca<sub>V</sub>1.2 and &#x003b2;-arrestin<sub>1/2</sub> upon AngII stimulation (Control: 0.18&#x02009;&#x000b1;&#x02009;0.05, n&#x02009;=&#x02009;6; AngII: 0.29&#x02009;&#x000b1;&#x02009;0.03, n&#x02009;=&#x02009;8; p&#x02009;&#x0003c;&#x02009;0.01), which suggests that &#x003b2;-arrestin is mobilized to the site of L-type calcium channel and thus, showing enhanced colocalization in acutely isolated rat cardiomyocytes.<fig id="Fig2"><label>Figure 2</label><caption><p>Ca<sub>V</sub>1.2 and &#x003b2;-arrestin<sub>1/2</sub> immunolocalization in adult cardiomyocytes. Representative confocal images of Ca<sub>V</sub>1.2 (left) or &#x003b2;-arrestin (middle) immunofluorescences in cardiomyocytes control <bold>(A)</bold> or treated with AngII (1&#x02009;&#x000b5;M) for 30&#x02009;min <bold>(B)</bold>, the overlay of individual images is shown on the right panel. All fluorescence images were collected at the same gain setting of the microscope. The images are representatives of 6 independent experiments.</p></caption><graphic xlink:href="41598_2017_10474_Fig2_HTML" id="d29e1280"/></fig>
</p><p id="Par24">Binding of &#x003b2;-arrestin to AT<sub>1</sub>R results not only in the desensitization of the heteromeric G-protein response, but also in the recruitment of various components of the endocytic machinery which promotes internalization of the activated receptors from the cell surface<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. To explore if binding of &#x003b2;-arrestin resulted in Ca<sub>V</sub>1.2 internalization, we performed antibody feeding experiments (see methods) in AD-293 cells overexpressing an extracellularly tagged Ca<sub>V</sub>1.2 subunit (HA-Ca<sub>V</sub>1.2) and AT<sub>1</sub>R (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). With this protocol, the channels that remained at the membrane were immunolabeled in no-permeabilized cells with a 488-green antibody, and the total of those channels initially localized at the cell surface (internalized plus those that remain at the membrane) immunolabeled with a 594-red antibody after permeabilized the cells with 0.5% triton, allowing for direct observation and relative quantification of internalized channels. Our results (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) demonstrate a robust loss of Ca<sub>V</sub>1.2 signal at the plasma membrane confirming that activation of AT<sub>1</sub>R indeed promotes the internalization of HA-tagged Ca<sub>V</sub>1.2 channels.<fig id="Fig3"><label>Figure 3</label><caption><p>Ca<sub>V</sub>1.2 internalization upon AngII exposure in overexpression system. <bold>(A)</bold> Confocal images of the distribution of HA-epitope-tagged Ca<sub>V</sub>1.2 constructs in AD-293 cells over-expressing Ca<sub>V</sub>1.2 (plus Ca<sub>V</sub>&#x003b2; and Ca<sub>V</sub>&#x003b1;<sub>2</sub>&#x003b4;) and AT<sub>1</sub>R before (top) or after (bottom) treatment with 1&#x02009;&#x000b5;M AngII (30&#x02009;min). <bold>(B)</bold> Summary bar graph showing the percentage of channels localized at the plasma membrane, normalized to control condition. n&#x02009;=&#x02009;6. *p&#x02009;&#x0003c;&#x02009;0.01 compared with control cells. No-perm, cells before permeabilization, representing the Ca<sub>V</sub>1.2 channels that remain at the plasma membrane; Perm, cell permeabilized that represent the total of channels localized at the cell surface at the beginning of the experiment.</p></caption><graphic xlink:href="41598_2017_10474_Fig3_HTML" id="d29e1359"/></fig>
</p><p id="Par25">Likewise, immunostaining of Ca<sub>V</sub>1.2 in rat cardiomyocytes treated with AngII, at different time points, revealed a gradual removal of Ca<sub>V</sub>1.2 channel from the T-tubules (Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">3</xref> and Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). This was significant in rat cardiomyocytes treated with AngII (1&#x02009;&#x000b5;M) for 1 hr (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4B and D</xref>) where predominantly surface sarcolemmal staining is observed. In contrast, rat cardiomyocytes simultaneously treated with a specific AT<sub>1</sub>R inhibitor (Losartan, 100&#x02009;nM, 1 hr) and AngII were undistinguishable from unstimulated cells (99.8&#x02009;&#x000b1;&#x02009;5.5%, n&#x02009;=&#x02009;4, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4C</xref>). These results suggest that only the LTCC population localized at the T-tubules is susceptible to internalization after prolonged AT<sub>1</sub>R activation.<fig id="Fig4"><label>Figure 4</label><caption><p>Ca<sub>V</sub>1.2 internalization in rat cardiomyocytes treated with AngII. Representative confocal images of Ca<sub>V</sub>1.2 immunofluorescence in rat cardiomyocytes, control <bold>(A)</bold> or treated with AngII (1&#x02009;&#x000b5;M) for 1 hr without <bold>(B)</bold> or with <bold>(C)</bold> losartan (100&#x02009;nM). All fluorescence images were collected at the same gain setting of the microscope, nucleus stained with DAPI. <bold>(D)</bold> Intracellular Ca<sub>V</sub>1.2 immunofluorescence staining intensity measurements normalized to control cardiomyocytes (n&#x02009;=&#x02009;6&#x02013;10 for each condition) from cardiomyocytes treated with AngII (1&#x02009;&#x000b5;M) for different time points. *p&#x02009;&#x0003c;&#x02009;0.01 with respect to control.</p></caption><graphic xlink:href="41598_2017_10474_Fig4_HTML" id="d29e1418"/></fig>
</p><p id="Par26">Control experiments involving &#x003b1;-actinin staining ruled out cardiomyocyte detubulation as an explanation of Ca<sub>V</sub>1.2 immunostaining loss after AngII treatment. In brief, an &#x003b1;-actinin antibody was used (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>) and the spacing between individual T-tubules was assessed by the power spectrum of each image after a fast Fourier transform of the signal. Thus, the power spike as a function of the spatial frequency describes the average distance between individual Z-discs in the cell (Control: 2.71&#x02009;&#x000b1;&#x02009;0.06 &#x003bc;m; AngII: 2.56&#x02009;&#x000b1;&#x02009;0.11 &#x003bc;m, n&#x02009;=&#x02009;5; NS), demonstrating that &#x003b1;-actinin immunostaining was independent of AngII treatment in our experimental conditions (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5A and C</xref>). Likewise, the average distance between Ca<sub>V</sub>1.2 immunostaining bands obtained in control cardiomyocytes (2.77&#x02009;&#x000b1;&#x02009;0.03 &#x003bc;m, n&#x02009;=&#x02009;5; Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5B</xref>), or in Ca<sub>V</sub>1.2 immunostaining treated with AngII and losartan (2.67&#x02009;&#x000b1;&#x02009;0.10 &#x003bc;m, n&#x02009;=&#x02009;4; Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">5</xref>) were identical, in contrast, the fast Fourier transformation of Ca<sub>V</sub>1.2 immunostaining from cardiomyocytes treated with AngII lacks in a peak (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5D</xref>), confirming that normal spacing of L-type channels is lost in these cardiomyocytes.<fig id="Fig5"><label>Figure 5</label><caption><p>T-tubule integrity in rat cardiomyocytes treated with AngII. <italic>Top:</italic> representative confocal images of rat ventricular cells stained with an anti-&#x003b1;-actinin antibody (<bold>A</bold>,<bold>C</bold>) or an anti-Ca<sub>V</sub>1.2 antibody (<bold>B</bold>,<bold>D</bold>). <italic>Middle</italic>: Fluorescence intensity profiles, in arbitrary units, along the longitudinal axis of each cardiomyocytes. <italic>Bottom</italic>: graphs of the fast Fourier transformation of the fluorescence profile. <bold>(A</bold>,<bold>B)</bold> control cardiomyocytes; <bold>(C</bold>,<bold>D)</bold> cardiomyocytes treated with AngII (1&#x02009;&#x000b5;M) for 1&#x02009;hr.</p></caption><graphic xlink:href="41598_2017_10474_Fig5_HTML" id="d29e1496"/></fig>
</p><p id="Par27">To test if the AT<sub>1</sub>R activation has functional consequences on Ca<sub>V</sub>1.2, we explored the effect of AngII on endogenous L-type calcium currents in adult rat cardiomyocytes. As seen in Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6A</xref>, AngII treatment (1&#x02009;hr, 1&#x02009;&#x000b5;M) induces a decrease of almost 60% of L-type calcium currents (I<sub>max, Control</sub> 12.1&#x02009;&#x000b1;&#x02009;1.8 pA/pF, n&#x02009;=&#x02009;8; I<sub>max, AngII</sub> 4.8&#x02009;&#x000b1;&#x02009;0.4 pA/pF, n&#x02009;=&#x02009;10; p&#x02009;&#x0003c;&#x02009;0.05) and a ~10 mv right-shift in the channel voltage dependence of activation as seen in representative I-V plots (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6B</xref>). L-type current kinetics were studied by fitting a single exponential to the rising phase (activation) or by setting up the residual current after 50 ms of pulse (R<sub>50</sub>) at different voltages (inactivation). We did not observe differences in the activation kinetics (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6C</xref>); however, cardiomyocytes treated with AngII displayed a faster inactivation kinetics as indicated by a decreased R<sub>50</sub> at all voltage tested (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6D</xref>). In agreement with our BRET experiments (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1E</xref>), a concentration dependent response, with an apparent IC<sub>50</sub> of ~300&#x02009;nM was observed for L-type current reduction (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6E</xref>, n&#x02009;=&#x02009;4&#x02013;10).<fig id="Fig6"><label>Figure 6</label><caption><p>Endogenous L-type currents from cardiomyocytes treated with AngII. <bold>(A)</bold> Representative whole-cell endogenous L-type Ca<sup>2+</sup> current traces from cardiomyocytes control (upper traces) or treated with AngII (1&#x02009;&#x000b5;M) for 1 hr (lower traces). Currents elicited by a voltage step protocol from &#x02013;60&#x02009;mV to&#x02009;+&#x02009;50&#x02009;mV in 10&#x02009;mV increments, V<sub>h</sub>&#x02009;=&#x02009;&#x02212;80 mV. <bold>(B)</bold> Summary peak current <italic>I/V</italic> plots (mean&#x02009;&#x000b1;&#x02009;sem) obtained from currents family as shown in <bold>(A)</bold>, black line represents the best fit to a Bolztman equation (see methods). <bold>(C)</bold> Voltage-dependence of the activation time constant (&#x003c4;<sub>act</sub>, mean&#x02009;&#x000b1;&#x02009;sem) of L-type Ca<sup>2+</sup> currents <bold>(D)</bold> Graph showing the residual current after 50 ms of the depolarization pulse (R<sub>50</sub>, mean&#x02009;&#x000b1;&#x02009;sem) versus command voltage of L-type Ca<sup>2+</sup> currents. Faster inactivation rates result in lower R<sub>50</sub> values. <bold>(E)</bold> Concentration-response curve of AngII-induced L-type calcium current reduction in rat cardiomyocytes, the line correspond to the best fit to Hill equation, mean values&#x02009;&#x000b1;&#x02009;sem are shown. In every panel, control rat cardiomyocytes are represented with empty circles and rat cardiomyocytes treated with AngII with filled circles. (n&#x02009;=&#x02009;4&#x02013;10) *p&#x02009;&#x0003c;&#x02009;0.01 with respect to control.</p></caption><graphic xlink:href="41598_2017_10474_Fig6_HTML" id="d29e1593"/></fig>
</p><p id="Par28">A reduction in L-type currents is predicted to have an impact on the magnitude and/or frequency of calcium transients and consequently, on cardiomyocyte contraction. To directly investigate this, we evaluated the effect of AngII on calcium mobilization and fractional shortening. Intracellular calcium was monitored in rat cardiomyocytes loaded with Fluo-4 and paced extracellularly with a 5 ms pulse at a frequency of 1&#x02009;Hz. Figure&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref> illustrates representative intracellular calcium transients recorded in adult rat cardiomyocytes, in control, and treated condition (AngII 1&#x02009;&#x000b5;M, 1 hr). As shown, calcium transients from rat cardiomyocytes exposed to AngII displayed a faster transient decay as compared to control (extracted from single exponential fits to the Ca<sup>2+</sup> transient decay; Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7D</xref>) suggesting that AngII also modifies SERCA activity<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. As expected from the reduced L-type calcium currents recorded, decreased calcium transient amplitudes are evident in rat cardiomyocytes treated with AngII (63.7&#x02009;&#x000b1;&#x02009;1.3% reduction, Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7C</xref>, p&#x02009;&#x0003c;&#x02009;0.05) together with slower time-to-peak. Moreover, fractional shortening assessment reveals that in rat cardiomyocytes stimulated at a frequency of 1&#x02009;Hz and treated with AngII, the fractional shortening was reduced to 30.7&#x02009;&#x000b1;&#x02009;3.7% (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7E</xref>), consistent with the observed reduction of the amplitude of calcium transients (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7C</xref>).<fig id="Fig7"><label>Figure 7</label><caption><p>Calcium transients in cardiomyocytes treated with AngII. Representative normalized fluorescence (Fluo-4) recordings from cardiomyocytes control <bold>(A)</bold> or treated with AngII (1&#x02009;&#x000b5;M) for 1&#x02009;hr <bold>(B)</bold> and stimulated with a 5 ms external stimulus (1&#x02009;Hz), individual points represent the signal for individual frames, acquire at 12&#x02009;Hz. Below each fluorescence recording the respective line-scan images are shown. Bar graph (mean&#x02009;&#x000b1;&#x02009;sem) of average maximal amplitude of electrically evoked Ca<sup>2+</sup> transients <bold>(C)</bold> or time constant of Ca<sup>2+</sup> decay <bold>(D)</bold> in cardiomyocytes control or treated with AngII (1&#x02009;&#x000b5;M) for 1&#x02009;hr. Data obtained after fitting individual calcium transients to a single exponential (n&#x02009;=&#x02009;30&#x02013;40, from 4 different cardiomyocytes preparations). *p&#x02009;&#x0003c;&#x02009;0.01 with respect to control. <bold>(E)</bold> Bar graph (mean&#x02009;&#x000b1;&#x02009;sem) of fractional shortening. For each bar graph, empty bars represents cardiomyocytes control and hatched bar cardiomyocytes treated with AngII (1&#x02009;&#x000b5;M) for 1&#x02009;hr. *p&#x02009;&#x0003c;&#x02009;0.01 with respect to control.</p></caption><graphic xlink:href="41598_2017_10474_Fig7_HTML" id="d29e1650"/></fig>
</p><p id="Par29">Finally, action potentials are the result of the concerted activation of many ion channels, each of which defines distinct aspects of its shape. Careful inspection of APs confers an integrative manner to investigate putative changes in other voltage-dependent ion channels as a result of AngII prolonged stimulation. Action potential duration from ventricular cardiomyocytes was determined as the time where 20%, 50% or 90% of repolarization was attained (APD<sub>20</sub>, APD<sub>50</sub> and APD<sub>90</sub>, respectively). Representative traces of superimposed APs from rat cardiomyocytes in control and after AngII treatment are displayed in Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8A</xref>. Quantification of the repolarization phase shows significant differences at APD<sub>90</sub> for AngII treated cardiomyocytes (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8C</xref>) suggesting that AngII treatment increases potassium currents in these cells. To examine other properties of the elicited action potentials, phase-plane plots were generated by graphing the voltage derivative in time (<italic>d</italic>V/<italic>dt</italic>) versus voltage as shown in Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8B</xref>. AngII treatment does not produce significant alterations in the threshold potential, the depolarization slope or the maximal depolarization voltage. Furthermore, the resting membrane potential (RMP) remains unaltered after AngII treatment (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8D and E</xref>) which evidences lack of modification of voltage dependent sodium currents by the current experimental manipulations.<fig id="Fig8"><label>Figure 8</label><caption><p>Action potentials from cardiomyocytes treated with AngII. <bold>(A)</bold> Representative action potentials waveforms from cardiomyocytes control (solid line) or treated with AngII (1&#x02009;&#x000b5;M) for 1 hr (dashed line). Action potentials were elicited with a short (2 ms) depolarizing current injections (200&#x02013;400&#x02009;pA) at a frequency of 1&#x02009;Hz. <bold>(B)</bold> Phase plot of the first derivative of membrane potential (d<italic>V</italic>/d<italic>t</italic>) against membrane potential (V<sub>m</sub>) for the action potentials shown in <bold>(A)</bold>. Control, empty symbols; AngII-treated, filled symbols. <bold>(C)</bold> Bar graphs (mean&#x02009;&#x000b1;&#x02009;sem) of average action potentials duration (APD) estimated at 20%, 50% and 90% repolarization, APD<sub>20</sub>, APD<sub>50</sub> and APD<sub>90</sub>, respectively. <bold>(D)</bold> Bar graph (mean&#x02009;&#x000b1;&#x02009;sem) of maximal action potential amplitudes (Overshoot), threshold potentials and mean resting membrane potentials (RMP). <bold>(E)</bold> Bar graph (mean&#x02009;&#x000b1;&#x02009;sem) of maximum rate of potentials change (<italic>dV</italic>/d<italic>t</italic>). For each bar graph, empty bars represents cardiomyocytes control and hatched bar cardiomyocytes treated with AngII (1&#x02009;&#x000b5;M) for 1&#x02009;hr. (n&#x02009;=&#x02009;7&#x02013;10) *p&#x02009;&#x0003c;&#x02009;0.01 with respect to control.</p></caption><graphic xlink:href="41598_2017_10474_Fig8_HTML" id="d29e1737"/></fig>
</p></sec><sec id="Sec15" sec-type="discussion"><title>Discussion</title><p id="Par30">GPCR-ion channel macrocomplexes are thought to optimize transductional coupling by preventing the diffusion of signaling molecules and by modulating ion channel trafficking, either through regulation of channel surface expression or by mediating receptor-dependent internalization. The internalization process is slower than the activation of heteromeric G proteins activation (that usually occurs within seconds) and involves &#x003b2;-arrestin binding to phosphorylated receptors<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>.</p><p id="Par31">The acute effects of AngII on L-type currents in cardiomyocytes have been extensively studied and appear to be species specific<sup><xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR24">24</xref></sup>, to depend on the experimental approach used<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> and/or on the different signaling molecules expressed<sup><xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref></sup>. In contrast, the prolonged effects of AngII on LTCC have received less attention. Prolonged AngII stimulation has been shown to increase the amount L-type current in newborn but not in adult mice cardiomyocytes<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. In HL-1 myocytes, although there is a consensus that prolonged AngII-stimulation also induces an increase of L-type current, the reason for this is controversial, with a report showing a main role for &#x003b2;-arrestin<sub>2</sub>
<sup><xref ref-type="bibr" rid="CR40">40</xref></sup> and other showing a CREB-dependent <italic>de novo</italic> expression of Ca<sub>V</sub>&#x003b1;<sub>1C</sub>
<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Moreover, a recent study in canine cardiomyocytes suggested a dependence on the transmural muscular layer<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>, suggesting the same species-specificity as for acute AngII stimulation.</p><p id="Par32">Here, we show that in cardiomyocytes from adult rat AngII increases &#x003b2;-arrestin<sub>1</sub> recruitment to L-type Ca<sup>2+</sup> channel and reduces L-type Ca<sup>2+</sup> current in a concentration-dependent manner, both processes with an EC<sub>50</sub> and an IC<sub>50</sub> in the order of ~100&#x02009;nM, respectively (Figs&#x000a0;<xref rid="Fig1" ref-type="fig">1E</xref> and <xref rid="Fig6" ref-type="fig">6E</xref>). This AngII concentration is orders of magnitude greater than the concentration of AngII found in plasma (in the order of pM). Nevertheless, it is in good agreement with recent literature showing that prolonged high-doses of AngII produce changes at the single cardiomyocyte level<sup><xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref></sup>. This difference suggests that local RAS may play a fundamental role in this process since plasma levels of AngII are too low to efficiently modify LTCC levels located at the T-tubules. In fact, recent estimates of AngII levels in canine and rat T-tubules are in the order of 100&#x02009;nM<sup><xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR44">44</xref></sup>. Thus, the local RAS at the heart<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> could be important for electrically remodeling cardiomyocytes from different muscle layers, generating regional heterogeneities in action potential morphology and contractility<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. Similarly, our experiments show that prolonged stimulation with AngII leads the internalization of the L-type channel population located at the T-tubules membrane (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>).</p><p id="Par33">It is generally agreed that the effects of AngII in the vasculature occur at low levels of this hormone which can be used to distinguish them from the effect of AngII in the cardiac system. This can be explained by differences in receptor affinity either by post translational modification or by the formation of tissue-specific macrocomplexes involving yet unidentified protein partners. However, more work is required to establish a clearer mechanistic understanding of this process.</p><p id="Par34">It should be noted that despite differences in the magnitude of the BRET signals obtained with different constructs (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> and Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>), the overall trend was consistent with a probable LTCC-&#x003b2;-arrestin<sub>1</sub> interaction. These results are supported by immunostaining data obtained from adult rat cardiomyocytes (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). We cannot ascertain the underlying reason for the difference in BRET signal amplitude, however some weight could be assigned to potentially different orientation of the energy transfer partners as the BRET signal depends on the orientation between donor and acceptor.</p><p id="Par35">More interestingly, the BRET experiments reveal a preference for &#x003b2;-arrestin<sub>1</sub> recruitment after AT<sub>1</sub>R activation as compared to &#x003b2;-arrestin<sub>2</sub>. When activated, the AT<sub>1</sub>R recruits both &#x003b2;-arrestin isoforms (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>), but ERK signaling pathway activation only occurs when &#x003b2;-arrestin<sub>2</sub> but not &#x003b2;-arrestin<sub>1</sub> is recruited<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. Thus, AT<sub>1</sub>R interaction with Ca<sub>V</sub>1.2 may represent a novel form of GPCR-dependent signaling regulation in which the presence of the macromolecular complex controls the specific recruitment of &#x003b2;-arrestin isoforms. Understandably, this hypothesis awaits experimental corroboration.</p><p id="Par36">Functionally, chronic activation of AT<sub>1</sub>R leads to the internalization of Ca<sub>V</sub>1.2 in a heterologous expression system (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) and in ventricular rat cardiomyocytes (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). Interestingly, internalization of Ca<sub>V</sub>1.2 in ventricular cardiomyocytes appears to be restricted to the population of channels present at the T-tubules known to mediate the calcium-induced calcium release process and the plateau phase of action potentials. In turn, the plasmalemma channel counterpart known to be involved in gene transcription regulation, seems unchanged by chronic stimulation with AngII. This subcellular loci-specific difference could be explained by the selective localization of AT<sub>1</sub>R at the T-tubules<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> supporting the idea of the existence of an AT<sub>1</sub>R/Ca<sub>V</sub>1.2 macrocomplex in these cells.</p><p id="Par37">As expected from the loss of Ca<sub>V</sub>1.2 signal at the T-tubule, L-type calcium currents are greatly reduced in cardiomyocytes treated with AngII (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6A</xref>). Interestingly, the remaining current display a 10&#x02009;mV right-shift in the I/V curve and a faster inactivation kinetics (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6B and D</xref>), which could be a consequence either of post-translational modification of the L-type channels (as oxidation or phosphorylation due to AT<sub>1</sub>R activation) or, as the observed current depends mainly on the LTCC present at the plasmalemma, an indicative that the different population of LTCC between the T-tubules and the plasmalemma bears different auxiliary subunits that grant them with differential biophysical characteristics. Nevertheless, in accordance with the diminished calcium current, the calcium transient amplitudes (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7C</xref>) and cardiomyocyte shortening (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7E</xref>) are similarly decreased. Nonetheless, AngII treatment is not specific for L-type channels, as Ca<sup>2+</sup>-reuptake is faster in AngII-treated cardiomyocytes (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7D</xref>) likely implicating higher activity of SERCA, suggesting that AngII treatment could induce more profound changes in calcium handling than those related to mere modification of the L-type current.</p><p id="Par38">Furthermore, action potential measurements (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>) allowed the monitoring of the coordinated behavior of various voltage-dependent ion channels. Despite a relatively low dependence of rat ventricular action potentials on L-type calcium currents, when compared with other species like rabbits or guinea pigs, the fact that the voltage threshold (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8D</xref>) and maximal <italic>d</italic>V/<italic>dt</italic> (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8E</xref>) were unaltered by AngII treatment clearly indicates that voltage-dependent Na<sup>+</sup> channels were unaffected. Likewise, unchanged resting membrane potential in AngII-treated cardiomyocytes suggests that &#x0201c;leak&#x0201d; K<sup>+</sup> channels are also unmodified. Both observations demonstrate that AngII-induced Ca<sub>V</sub>1.2 channel internalization does not imply an unselective effect on ion channels. In contrast, changes in APD<sub>90</sub> suggest that in these tissues, a voltage-dependent K<sup>+</sup>-channel is activated by chronic AT<sub>1</sub>R stimulation which is yet to be identified.</p><p id="Par39">Concerning the fate of the Ca<sub>V</sub>1.2 channels after prolonged AngII stimulation, those channels could be targeted either for degradation or for recycling after its internalization. In fact, a closer look of the plasmalemma-arising signal of rat cardiomyocytes treated with AngII (Figs&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="Fig5" ref-type="fig">5</xref> and Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">4</xref>) indicates a more continuous signal at the membrane edge when stained with a Ca<sub>V</sub>1.2 antibody, suggesting that at least part of the channels originally in the T-tubule network could be re-targeted to the plasmalemma. At the same time, as depicted from the signal loss of Ca<sub>V</sub>1.2 total intensity when AngII-treated cardiomyocytes are compared with control cardiomyocytes, part of the channels appear to be directed to degradation.</p><p id="Par40">AT<sub>1</sub>R activation is well known to activate a series of intracellular signaling pathways<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>, those channels remaining at the membrane are likely to undergo posttranslational modification, such as PKC or CaMKII-dependent phosphorylation. Interestingly, these signals are usually associated with activation of the L-type current<sup><xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref></sup>, suggesting that after prolonged AngII stimulation the channels in the plasmalemma, usually associated with gene transcription, are more active emphasizing the role of the process described here in cardiac remodeling.</p><p id="Par41">In summary, we demonstrate a novel signaling pathway involving AT<sub>1</sub>R activation and LTCC. This AngII-dependent intracellular signaling pathway selectively recruits &#x003b2;-arrestin<sub>1</sub> after receptor activation, promoting internalization of Ca<sub>V</sub>1.2 channels. In adult rat cardiomyocytes, the AngII driven internalization of Ca<sub>V</sub>1.2 occurs almost exclusively at the T-tubules leading to a significant reduction of L-type calcium current and calcium transient amplitudes. Functionally, the results presented here provide insights into the mechanisms by which prolonged AngII exposure causes cardiac remodeling and could have major implications for understanding the molecular mechanisms controlling the electrical transmural gradient observed in the heart.</p></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec16"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2017_10474_MOESM1_ESM.pdf"><caption><p>Supplemental Figures</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p>Tamara Hermosilla and Mat&#x000ed;as Encina contributed equally to this work.</p></fn><fn><p><bold>Electronic supplementary material</bold></p><p>
<bold>Supplementary information</bold> accompanies this paper at doi:10.1038/s41598-017-10474-z
</p></fn><fn><p>
<bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We are thankful to Rocio K. Finol-Urdaneta, Jeffrey R. McArthur, Luis Michea and Andres Stutzin for constructive discussion of the manuscript. We thank to Iniciativa Cientifica Milenio. This work was supported by research grants from Fondo Nacional de Desarrollo Cient&#x000ed;fico y Tecnol&#x000f3;gico (Fondecyt) 1120240 and 1160900 to DV; Fondecyt 1121078 and Millennium Institute on Immunology and Immunotherapy P09-016-F to FS. CA holds a Tier2 Canada Research Chair, and is funded by both the Canadian Institutes of Health Research (CIHR) and Natural Sciences and Engineering Research Council (NSERC).</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>D.V., T.H., C.A., designed the project. T.H., M.E., D.M., C.M., H.M.A.V., C.C., F.L.-M. and D.V. performed the experiments. D.V., T.H. and F.S. analyzed the data. D.V. wrote the manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar1"><title>Competing Interests</title><p id="Par42">The authors declare that they have no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-Ortega</surname><given-names>M</given-names></name><etal/></person-group><article-title>Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases</article-title><source>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association</source><year>2006</year><volume>21</volume><fpage>16</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfi265</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>TH</given-names></name><name><surname>Grossmann</surname><given-names>M</given-names></name><name><surname>Ji</surname><given-names>I</given-names></name></person-group><article-title>G protein-coupled receptors. I. Diversity of receptor-ligand interactions</article-title><source>The Journal of biological chemistry</source><year>1998</year><volume>273</volume><fpage>17299</fpage><lpage>17302</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.28.17299</pub-id><?supplied-pmid 9651309?><pub-id pub-id-type="pmid">9651309</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>S</given-names></name><name><surname>Saku</surname><given-names>K</given-names></name><name><surname>Karnik</surname><given-names>SS</given-names></name></person-group><article-title>Molecular analysis of the structure and function of the angiotensin II type 1 receptor</article-title><source>Hypertension research: official journal of the Japanese Society of Hypertension</source><year>2003</year><volume>26</volume><fpage>937</fpage><lpage>943</lpage><pub-id pub-id-type="doi">10.1291/hypres.26.937</pub-id><pub-id pub-id-type="pmid">14717335</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luttrell</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes</article-title><source>Science</source><year>1999</year><volume>283</volume><fpage>655</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1126/science.283.5402.655</pub-id><?supplied-pmid 9924018?><pub-id pub-id-type="pmid">9924018</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>ZM</given-names></name><name><surname>Gold</surname><given-names>JI</given-names></name><name><surname>Koch</surname><given-names>WJ</given-names></name></person-group><article-title>G protein-coupled receptor kinases in normal and failing myocardium</article-title><source>Frontiers in bioscience</source><year>2011</year><volume>16</volume><fpage>3047</fpage><lpage>3060</lpage><pub-id pub-id-type="doi">10.2741/3898</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>FJ</given-names></name><etal/></person-group><article-title>Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor</article-title><source>Cell</source><year>2002</year><volume>111</volume><fpage>219</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(02)00962-5</pub-id><?supplied-pmid 12408866?><pub-id pub-id-type="pmid">12408866</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>AK</given-names></name><etal/></person-group><article-title>Arresting a transient receptor potential (TRP) channel: beta-arrestin 1 mediates ubiquitination and functional down-regulation of TRPV4</article-title><source>The Journal of biological chemistry</source><year>2010</year><volume>285</volume><fpage>30115</fpage><lpage>30125</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.141549</pub-id><?supplied-pmid 20650893?><pub-id pub-id-type="pmid">20650893</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doronin</surname><given-names>SV</given-names></name><name><surname>Potapova</surname><given-names>IA</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Cohen</surname><given-names>IS</given-names></name></person-group><article-title>Angiotensin receptor type 1 forms a complex with the transient outward potassium channel Kv4.3 and regulates its gating properties and intracellular localization</article-title><source>The Journal of biological chemistry</source><year>2004</year><volume>279</volume><fpage>48231</fpage><lpage>48237</lpage><pub-id pub-id-type="doi">10.1074/jbc.M405789200</pub-id><?supplied-pmid 15342638?><pub-id pub-id-type="pmid">15342638</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beedle</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Agonist-independent modulation of N-type calcium channels by ORL1 receptors</article-title><source>Nature neuroscience</source><year>2004</year><volume>7</volume><fpage>118</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1038/nn1180</pub-id><?supplied-pmid 14730309?><pub-id pub-id-type="pmid">14730309</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HW</given-names></name><name><surname>Jung</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>KH</given-names></name><name><surname>Baik</surname><given-names>JH</given-names></name><name><surname>Rhim</surname><given-names>H</given-names></name></person-group><article-title>Direct interaction and functional coupling between voltage-gated CaV1.3 Ca2+ channel and GABAB receptor subunit 2</article-title><source>FEBS letters</source><year>2010</year><volume>584</volume><fpage>3317</fpage><lpage>3322</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2010.07.014</pub-id><?supplied-pmid 20627102?><pub-id pub-id-type="pmid">20627102</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kisilevsky</surname><given-names>AE</given-names></name><etal/></person-group><article-title>D1 receptors physically interact with N-type calcium channels to regulate channel distribution and dendritic calcium entry</article-title><source>Neuron</source><year>2008</year><volume>58</volume><fpage>557</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2008.03.002</pub-id><?supplied-pmid 18498737?><pub-id pub-id-type="pmid">18498737</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kisilevsky</surname><given-names>AE</given-names></name><name><surname>Zamponi</surname><given-names>GW</given-names></name></person-group><article-title>D2 dopamine receptors interact directly with N-type calcium channels and regulate channel surface expression levels</article-title><source>Channels</source><year>2008</year><volume>2</volume><fpage>269</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.4161/chan.2.4.6402</pub-id><?supplied-pmid 18719394?><pub-id pub-id-type="pmid">18719394</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altier</surname><given-names>C</given-names></name><etal/></person-group><article-title>ORL1 receptor-mediated internalization of N-type calcium channels</article-title><source>Nature neuroscience</source><year>2006</year><volume>9</volume><fpage>31</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1038/nn1605</pub-id><?supplied-pmid 16311589?><pub-id pub-id-type="pmid">16311589</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simms</surname><given-names>BA</given-names></name><name><surname>Zamponi</surname><given-names>GW</given-names></name></person-group><article-title>Trafficking and stability of voltage-gated calcium channels</article-title><source>Cellular and molecular life sciences: CMLS</source><year>2012</year><volume>69</volume><fpage>843</fpage><lpage>856</lpage><pub-id pub-id-type="doi">10.1007/s00018-011-0843-y</pub-id><?supplied-pmid 21964928?><pub-id pub-id-type="pmid">21964928</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Best</surname><given-names>JM</given-names></name><name><surname>Kamp</surname><given-names>TJ</given-names></name></person-group><article-title>Different subcellular populations of L-type Ca2+ channels exhibit unique regulation and functional roles in cardiomyocytes</article-title><source>Journal of molecular and cellular cardiology</source><year>2012</year><volume>52</volume><fpage>376</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2011.08.014</pub-id><?supplied-pmid 21888911?><pub-id pub-id-type="pmid">21888911</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beech</surname><given-names>DJ</given-names></name></person-group><article-title>Actions of neurotransmitters and other messengers on Ca2+ channels and K+ channels in smooth muscle cells</article-title><source>Pharmacol Ther</source><year>1997</year><volume>73</volume><fpage>91</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/S0163-7258(97)87271-3</pub-id><?supplied-pmid 9131720?><pub-id pub-id-type="pmid">9131720</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quignard</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Phosphoinositide 3-kinase gamma mediates angiotensin II-induced stimulation of L-type calcium channels in vascular myocytes</article-title><source>The Journal of biological chemistry</source><year>2001</year><volume>276</volume><fpage>32545</fpage><lpage>32551</lpage><pub-id pub-id-type="doi">10.1074/jbc.M102582200</pub-id><?supplied-pmid 11443116?><pub-id pub-id-type="pmid">11443116</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seki</surname><given-names>T</given-names></name><name><surname>Yokoshiki</surname><given-names>H</given-names></name><name><surname>Sunagawa</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Sperelakis</surname><given-names>N</given-names></name></person-group><article-title>Angiotensin II stimulation of Ca2+ -channel current in vascular smooth muscle cells is inhibited by lavendustin-A and LY-294002</article-title><source>Pflugers Archiv: European journal of physiology</source><year>1999</year><volume>437</volume><fpage>317</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1007/s004240050785</pub-id><?supplied-pmid 9914387?><pub-id pub-id-type="pmid">9914387</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callewaert</surname><given-names>G</given-names></name><name><surname>Hanbauer</surname><given-names>I</given-names></name><name><surname>Morad</surname><given-names>M</given-names></name></person-group><article-title>Modulation of calcium channels in cardiac and neuronal cells by an endogenous peptide</article-title><source>Science</source><year>1989</year><volume>243</volume><fpage>663</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1126/science.2536955</pub-id><?supplied-pmid 2536955?><pub-id pub-id-type="pmid">2536955</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikegami</surname><given-names>H</given-names></name><name><surname>Endoh</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name></person-group><article-title>Angiotensin II-induced inhibition of calcium currents in hamster submandibular ganglion neurons</article-title><source>Neuroscience research</source><year>2001</year><volume>41</volume><fpage>227</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/S0168-0102(01)00279-6</pub-id><?supplied-pmid 11672835?><pub-id pub-id-type="pmid">11672835</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maturana</surname><given-names>AD</given-names></name><etal/></person-group><article-title>Angiotensin II negatively modulates L-type calcium channels through a pertussis toxin-sensitive G protein in adrenal glomerulosa cells</article-title><source>The Journal of biological chemistry</source><year>1999</year><volume>274</volume><fpage>19943</fpage><lpage>19948</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.28.19943</pub-id><?supplied-pmid 10391942?><pub-id pub-id-type="pmid">10391942</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Mello</surname><given-names>WC</given-names></name><name><surname>Monterrubio</surname><given-names>J</given-names></name></person-group><article-title>Intracellular and extracellular angiotensin II enhance the L-type calcium current in the failing heart</article-title><source>Hypertension</source><year>2004</year><volume>44</volume><fpage>360</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000139914.52686.74</pub-id><?supplied-pmid 15289467?><pub-id pub-id-type="pmid">15289467</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichiyanagi</surname><given-names>O</given-names></name><name><surname>Ishii</surname><given-names>K</given-names></name><name><surname>Endoh</surname><given-names>M</given-names></name></person-group><article-title>Angiotensin II increases L-type Ca2&#x02009;+&#x02009;current in gramicidin D-perforated adult rabbit ventricular myocytes: comparison with conventional patch-clamp method</article-title><source>Pflugers Archiv: European journal of physiology</source><year>2002</year><volume>444</volume><fpage>107</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1007/s00424-002-0808-y</pub-id><?supplied-pmid 11976922?><pub-id pub-id-type="pmid">11976922</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aiello</surname><given-names>EA</given-names></name><name><surname>Cingolani</surname><given-names>HE</given-names></name></person-group><article-title>Angiotensin II stimulates cardiac L-type Ca(2+) current by a Ca(2+)- and protein kinase C-dependent mechanism</article-title><source>American journal of physiology. Heart and circulatory physiology</source><year>2001</year><volume>280</volume><fpage>H1528</fpage><lpage>1536</lpage><?supplied-pmid 11247763?><pub-id pub-id-type="pmid">11247763</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Mello</surname><given-names>WC</given-names></name></person-group><article-title>Intracellular angiotensin II regulates the inward calcium current in cardiac myocytes</article-title><source>Hypertension</source><year>1998</year><volume>32</volume><fpage>976</fpage><lpage>982</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.32.6.976</pub-id><?supplied-pmid 9856960?><pub-id pub-id-type="pmid">9856960</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bkaily</surname><given-names>G</given-names></name><etal/></person-group><article-title>Angiotensin II-induced increase of T-type Ca2+ current and decrease of L-type Ca2+ current in heart cells</article-title><source>Peptides</source><year>2005</year><volume>26</volume><fpage>1410</fpage><lpage>1417</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2005.03.021</pub-id><?supplied-pmid 16042981?><pub-id pub-id-type="pmid">16042981</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermosilla</surname><given-names>T</given-names></name><etal/></person-group><article-title>L-type calcium channel beta subunit modulates angiotensin II responses in cardiomyocytes</article-title><source>Channels</source><year>2011</year><volume>5</volume><fpage>280</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.4161/chan.5.3.15833</pub-id><?supplied-pmid 21525790?><pub-id pub-id-type="pmid">21525790</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno</surname><given-names>C</given-names></name><etal/></person-group><article-title>Cavbeta2 transcription start site variants modulate calcium handling in newborn rat cardiomyocytes</article-title><source>Pflugers Archiv: European journal of physiology</source><year>2015</year><volume>467</volume><fpage>2473</fpage><lpage>2484</lpage><pub-id pub-id-type="doi">10.1007/s00424-015-1723-3</pub-id><?supplied-pmid 26265381?><pub-id pub-id-type="pmid">26265381</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altier</surname><given-names>C</given-names></name><etal/></person-group><article-title>The Cavbeta subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels</article-title><source>Nature neuroscience</source><year>2011</year><volume>14</volume><fpage>173</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1038/nn.2712</pub-id><?supplied-pmid 21186355?><pub-id pub-id-type="pmid">21186355</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><etal/></person-group><article-title>A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization</article-title><source>The Journal of neuroscience: the official journal of the Society for Neuroscience</source><year>2004</year><volume>24</volume><fpage>4070</fpage><lpage>4081</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0346-04.2004</pub-id><pub-id pub-id-type="pmid">15102922</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varela</surname><given-names>D</given-names></name><name><surname>Niemeyer</surname><given-names>MI</given-names></name><name><surname>Cid</surname><given-names>LP</given-names></name><name><surname>Sepulveda</surname><given-names>FV</given-names></name></person-group><article-title>Effect of an N-terminus deletion on voltage-dependent gating of the ClC-2 chloride channel</article-title><source>The Journal of physiology</source><year>2002</year><volume>544</volume><fpage>363</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2002.026096</pub-id><?supplied-pmid 12381811?><pub-id pub-id-type="pmid">12381811</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauliere</surname><given-names>A</given-names></name><etal/></person-group><article-title>Deciphering biased-agonism complexity reveals a new active AT1 receptor entity</article-title><source>Nature chemical biology</source><year>2012</year><volume>8</volume><fpage>622</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1038/nchembio.961</pub-id><?supplied-pmid 22634635?><pub-id pub-id-type="pmid">22634635</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmann</surname><given-names>F</given-names></name><name><surname>Belkacemi</surname><given-names>A</given-names></name><name><surname>Flockerzi</surname><given-names>V</given-names></name></person-group><article-title>Emerging Alternative Functions for the Auxiliary Subunits of the Voltage-Gated Calcium Channels</article-title><source>Curr Mol Pharmacol</source><year>2015</year><volume>8</volume><fpage>162</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.2174/1874467208666150507110202</pub-id><?supplied-pmid 25966689?><pub-id pub-id-type="pmid">25966689</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanni</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>beta-Arrestin 1 and 2 stabilize the angiotensin II type I receptor in distinct high-affinity conformations</article-title><source>British journal of pharmacology</source><year>2010</year><volume>161</volume><fpage>150</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.2010.00875.x</pub-id><?supplied-pmid 20718747?><pub-id pub-id-type="pmid">20718747</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>RM</given-names></name><name><surname>Colecraft</surname><given-names>HM</given-names></name></person-group><article-title>L-type calcium channel targeting and local signalling in cardiac myocytes</article-title><source>Cardiovascular research</source><year>2013</year><volume>98</volume><fpage>177</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvt021</pub-id><?supplied-pmid 23417040?><pub-id pub-id-type="pmid">23417040</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritter</surname><given-names>SL</given-names></name><name><surname>Hall</surname><given-names>RA</given-names></name></person-group><article-title>Fine-tuning of GPCR activity by receptor-interacting proteins</article-title><source>Nature reviews. Molecular cell biology</source><year>2009</year><volume>10</volume><fpage>819</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1038/nrm2803</pub-id><?supplied-pmid 19935667?><pub-id pub-id-type="pmid">19935667</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>B</given-names></name><name><surname>Gupta</surname><given-names>C</given-names></name><name><surname>Shukla</surname><given-names>AK</given-names></name></person-group><article-title>Emerging Functional Divergence of beta-Arrestin Isoforms in GPCR Function</article-title><source>Trends in endocrinology and metabolism: TEM</source><year>2015</year><volume>26</volume><fpage>628</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2015.09.001</pub-id><?supplied-pmid 26471844?><pub-id pub-id-type="pmid">26471844</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>S</given-names></name><name><surname>Doan</surname><given-names>T</given-names></name><name><surname>Bernstein</surname><given-names>KE</given-names></name><name><surname>Dascal</surname><given-names>N</given-names></name></person-group><article-title>Modulation of cardiac Ca2+ channel by Gq-activating neurotransmitters reconstituted in Xenopus oocytes</article-title><source>The Journal of biological chemistry</source><year>2004</year><volume>279</volume><fpage>12503</fpage><lpage>12510</lpage><pub-id pub-id-type="doi">10.1074/jbc.M310196200</pub-id><?supplied-pmid 14722109?><pub-id pub-id-type="pmid">14722109</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conforti</surname><given-names>L</given-names></name><name><surname>Sumii</surname><given-names>K</given-names></name><name><surname>Sperelakis</surname><given-names>N</given-names></name></person-group><article-title>Dioctanoyl-glycerol inhibits L-type calcium current in embryonic chick cardiomyocytes independent of protein kinase C activation</article-title><source>Journal of molecular and cellular cardiology</source><year>1995</year><volume>27</volume><fpage>1219</fpage><lpage>1224</lpage><pub-id pub-id-type="doi">10.1016/0022-2828(95)90058-6</pub-id><?supplied-pmid 7473780?><pub-id pub-id-type="pmid">7473780</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashihara</surname><given-names>T</given-names></name><name><surname>Nakada</surname><given-names>T</given-names></name><name><surname>Kojima</surname><given-names>K</given-names></name><name><surname>Takeshita</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name></person-group><article-title>Angiotensin II activates CaV 1.2 Ca2+ channels through beta-arrestin2 and casein kinase 2 in mouse immature cardiomyocytes</article-title><source>The Journal of physiology</source><year>2017</year><volume>595</volume><fpage>4207</fpage><lpage>4225</lpage><pub-id pub-id-type="doi">10.1113/JP273883</pub-id><?supplied-pmid 28295363?><pub-id pub-id-type="pmid">28295363</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>CT</given-names></name><etal/></person-group><article-title>Angiotensin II increases expression of alpha1C subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding protein-dependent pathway in HL-1 myocytes</article-title><source>Circ Res</source><year>2007</year><volume>100</volume><fpage>1476</fpage><lpage>1485</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000268497.93085.e1</pub-id><?supplied-pmid 17463319?><pub-id pub-id-type="pmid">17463319</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>J</given-names></name><etal/></person-group><article-title>Autocrine A2 in the T-system of ventricular myocytes creates transmural gradients in ion transport: a mechanism to match contraction with load?</article-title><source>Biophysical journal</source><year>2014</year><volume>106</volume><fpage>2364</fpage><lpage>2374</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2014.04.042</pub-id><?supplied-pmid 24896115?><pub-id pub-id-type="pmid">24896115</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Cohen</surname><given-names>IS</given-names></name><name><surname>Mathias</surname><given-names>RT</given-names></name></person-group><article-title>Angiotensin II Type 1 Receptor-Mediated Electrical Remodeling in Mouse Cardiac Myocytes</article-title><source>PloS one</source><year>2015</year><volume>10</volume><pub-id pub-id-type="doi">10.1371/journal.pone.0138711</pub-id><?supplied-pmid 26430746?><pub-id pub-id-type="pmid">26430746</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saris</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Prorenin-induced myocyte proliferation: no role for intracellular angiotensin II</article-title><source>Hypertension</source><year>2002</year><volume>39</volume><fpage>573</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1161/hy0202.103002</pub-id><?supplied-pmid 11882610?><pub-id pub-id-type="pmid">11882610</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Kats</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions</article-title><source>Circulation</source><year>1998</year><volume>98</volume><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.98.1.73</pub-id><?supplied-pmid 9665063?><pub-id pub-id-type="pmid">9665063</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>RB</given-names></name><name><surname>Bouchard</surname><given-names>RA</given-names></name><name><surname>Salinas-Stefanon</surname><given-names>E</given-names></name><name><surname>Sanchez-Chapula</surname><given-names>J</given-names></name><name><surname>Giles</surname><given-names>WR</given-names></name></person-group><article-title>Heterogeneity of action potential waveforms and potassium currents in rat ventricle</article-title><source>Cardiovascular research</source><year>1993</year><volume>27</volume><fpage>1795</fpage><lpage>1799</lpage><pub-id pub-id-type="doi">10.1093/cvr/27.10.1795</pub-id><?supplied-pmid 8275526?><pub-id pub-id-type="pmid">8275526</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Garrison</surname><given-names>TR</given-names></name><name><surname>Lefkowitz</surname><given-names>RJ</given-names></name></person-group><article-title>Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2</article-title><source>The Journal of biological chemistry</source><year>2004</year><volume>279</volume><fpage>7807</fpage><lpage>7811</lpage><pub-id pub-id-type="doi">10.1074/jbc.C300443200</pub-id><?supplied-pmid 14711824?><pub-id pub-id-type="pmid">14711824</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>M</given-names></name><etal/></person-group><article-title>Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction</article-title><source>American journal of physiology. Heart and circulatory physiology</source><year>2005</year><volume>288</volume><fpage>H317</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00957.2003</pub-id><?supplied-pmid 15374832?><pub-id pub-id-type="pmid">15374832</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Mende</surname><given-names>U</given-names></name></person-group><article-title>Regulators of G-protein signaling in the heart and their potential as therapeutic targets</article-title><source>Circ Res</source><year>2011</year><volume>109</volume><fpage>320</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.231423</pub-id><?supplied-pmid 21778436?><pub-id pub-id-type="pmid">21778436</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swaminathan</surname><given-names>PD</given-names></name><etal/></person-group><article-title>Oxidized CaMKII causes cardiac sinus node dysfunction in mice</article-title><source>J Clin Invest</source><year>2011</year><volume>121</volume><fpage>3277</fpage><lpage>3288</lpage><pub-id pub-id-type="doi">10.1172/JCI57833</pub-id><?supplied-pmid 21785215?><pub-id pub-id-type="pmid">21785215</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Protein kinase C isoforms differentially phosphorylate Ca(v)1.2 alpha(1c)</article-title><source>Biochemistry</source><year>2009</year><volume>48</volume><fpage>6674</fpage><lpage>6683</lpage><pub-id pub-id-type="doi">10.1021/bi900322a</pub-id><?supplied-pmid 19527072?><pub-id pub-id-type="pmid">19527072</pub-id></element-citation></ref></ref-list></back></article>